| Primary |
| Product Used For Unknown Indication |
73.2% |
| Hyperparathyroidism Secondary |
8.8% |
| Maternal Exposure Timing Unspecified |
6.3% |
| Renal Failure Chronic |
2.9% |
| Hypertension |
1.7% |
| Drug Use For Unknown Indication |
1.3% |
| Hypocalcaemia |
1.3% |
| Renal Failure |
1.3% |
| Anaemia |
0.8% |
| Pancreatic Carcinoma |
0.8% |
| Blood Cholesterol Increased |
0.4% |
| Diuretic Therapy |
0.4% |
| Hyperparathyroidism |
0.4% |
| Vitamin D Deficiency |
0.4% |
|
| Death |
13.3% |
| Coronary Artery Disease |
10.0% |
| Bladder Transitional Cell Carcinoma |
6.7% |
| Hospitalisation |
6.7% |
| Sudden Cardiac Death |
6.7% |
| Tonsillectomy |
6.7% |
| Vascular Calcification |
6.7% |
| Caesarean Section |
3.3% |
| Catheterisation Cardiac |
3.3% |
| Dizziness |
3.3% |
| Gastroenteritis |
3.3% |
| Hip Fracture |
3.3% |
| Hyperparathyroidism Secondary |
3.3% |
| Hyperparathyroidism Tertiary |
3.3% |
| Hypertension |
3.3% |
| Nausea |
3.3% |
| Neoplasm Skin |
3.3% |
| Osteomalacia |
3.3% |
| Parathyroidectomy |
3.3% |
| Pneumonia |
3.3% |
|
| Secondary |
| Product Used For Unknown Indication |
57.3% |
| Drug Use For Unknown Indication |
15.9% |
| Hyperparathyroidism Secondary |
11.0% |
| Hyperparathyroidism |
3.7% |
| Anaemia |
2.4% |
| Hypertension |
2.4% |
| Renal Failure Chronic |
2.4% |
| Hyperparathyroidism Primary |
1.2% |
| Hypocalcaemia |
1.2% |
| Mitral Valve Replacement |
1.2% |
| Prophylaxis Of Abortion |
1.2% |
|
| Neoplasm Skin |
30.8% |
| Sudden Cardiac Death |
15.4% |
| Blood Parathyroid Hormone Increased |
7.7% |
| Calciphylaxis |
7.7% |
| Pain In Extremity |
7.7% |
| Premature Rupture Of Membranes |
7.7% |
| Thrombosis |
7.7% |
| Venous Stenosis |
7.7% |
| Vomiting |
7.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.7% |
| Drug Use For Unknown Indication |
13.8% |
| Nuclear Magnetic Resonance Imaging |
13.7% |
| Hyperparathyroidism Secondary |
9.5% |
| Angiogram |
5.9% |
| Nephrogenic Anaemia |
4.4% |
| Hypertension |
3.5% |
| Imaging Procedure |
3.0% |
| Renal Failure Chronic |
2.5% |
| Nuclear Magnetic Resonance Imaging Brain |
2.3% |
| Pancreas Transplant |
2.1% |
| Hyperphosphataemia |
2.0% |
| Cardiac Failure |
1.8% |
| Dialysis |
1.8% |
| Cardiac Disorder |
1.6% |
| Nuclear Magnetic Resonance Imaging Abdominal |
1.4% |
| Anaemia |
1.3% |
| Aortogram |
1.3% |
| Computerised Tomogram |
1.3% |
| Cardiac Failure Chronic |
1.1% |
|
| Hypocalcaemia |
8.8% |
| Skin Fibrosis |
7.5% |
| Purpura |
6.3% |
| Renal Failure |
6.3% |
| Skin Tightness |
6.3% |
| Venous Insufficiency |
6.3% |
| Vomiting |
6.3% |
| General Physical Health Deterioration |
5.0% |
| Nephrogenic Systemic Fibrosis |
5.0% |
| Oedema Peripheral |
5.0% |
| Skin Cancer |
5.0% |
| Angina Pectoris |
3.8% |
| Asthenia |
3.8% |
| Cerebral Ischaemia |
3.8% |
| Paraesthesia |
3.8% |
| Sepsis |
3.8% |
| Spinal Compression Fracture |
3.8% |
| Treatment Noncompliance |
3.8% |
| Tremor |
3.8% |
| Acute Pulmonary Oedema |
2.5% |
|
